Export

Amphotericin B
Essential medicine status
Section:
6. Anti-infective medicines 6.3. Antifungal medicines
ATC codes: J02AA01
EMLc
Indication
Aspergillosis ICD11 code: 1F20.Z
INN
Amphotericin B
Medicine type
Chemical agent
List type
Core
Formulations
Parenteral > General injections > IV: 50 mg powder for injection in vial (as deoxycholate or liposomal complex)
EML status history
First added in 1977 (TRS 615)
Changed in 1979 (TRS 641)
Changed in 1984 (TRS 722)
Changed in 2003 (TRS 920)
Changed in 2007 (TRS 950)
Changed in 2009 (TRS 958)
Changed in 2013 (TRS 985)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
Amphotericin B
DrugBank
Amphotericin b
Summary of evidence and Expert Committee recommendations
Amphotericin B for the treatment of systemic fungal infections was moved from the complementary to the core list of the EML and EMLc.